Germany · Delayed Price · Currency is EUR innoscripta SE Statistics
Total Valuation
innoscripta SE has a market cap or net worth of EUR 755.00 million. The enterprise value is 698.25 million.
| Market Cap | 755.00M |
| Enterprise Value | 698.25M |
Important Dates
The next estimated earnings date is Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | Apr 22, 2026 |
Share Statistics
innoscripta SE has 10.00 million shares outstanding.
| Current Share Class | 10.00M |
| Shares Outstanding | 10.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 6.08% |
| Float | 1.69M |
Valuation Ratios
The trailing PE ratio is 15.08 and the forward PE ratio is 13.07. innoscripta SE's PEG ratio is 0.42.
| PE Ratio | 15.08 |
| Forward PE | 13.07 |
| PS Ratio | 6.39 |
| PB Ratio | 10.46 |
| P/TBV Ratio | 10.47 |
| P/FCF Ratio | 15.38 |
| P/OCF Ratio | 15.21 |
| PEG Ratio | 0.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.35, with an EV/FCF ratio of 14.23.
| EV / Earnings | 13.95 |
| EV / Sales | 5.91 |
| EV / EBITDA | 9.35 |
| EV / EBIT | 9.38 |
| EV / FCF | 14.23 |
Financial Position
The company has a current ratio of 3.38, with a Debt / Equity ratio of 0.16.
| Current Ratio | 3.38 |
| Quick Ratio | 3.23 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.24 |
| Interest Coverage | 612.68 |
Financial Efficiency
Return on equity (ROE) is 84.67% and return on invested capital (ROIC) is 284.85%.
| Return on Equity (ROE) | 84.67% |
| Return on Assets (ROA) | 46.64% |
| Return on Invested Capital (ROIC) | 284.85% |
| Return on Capital Employed (ROCE) | 84.51% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 366,827 |
| Profits Per Employee | 155,474 |
| Employee Count | 322 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 31.52 |
Taxes
In the past 12 months, innoscripta SE has paid 24.56 million in taxes.
| Income Tax | 24.56M |
| Effective Tax Rate | 32.91% |
Stock Price Statistics
The stock price has decreased by -25.25% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -25.25% |
| 50-Day Moving Average | 75.89 |
| 200-Day Moving Average | 89.49 |
| Relative Strength Index (RSI) | 41.34 |
| Average Volume (20 Days) | 7,396 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, innoscripta SE had revenue of EUR 118.12 million and earned 50.06 million in profits.
| Revenue | 118.12M |
| Gross Profit | 85.62M |
| Operating Income | 74.47M |
| Pretax Income | 74.62M |
| Net Income | 50.06M |
| EBITDA | 74.70M |
| EBIT | 74.47M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 68.66 million in cash and 11.90 million in debt, with a net cash position of 56.75 million or 5.68 per share.
| Cash & Cash Equivalents | 68.66M |
| Total Debt | 11.90M |
| Net Cash | 56.75M |
| Net Cash Per Share | 5.68 |
| Equity (Book Value) | 72.17M |
| Book Value Per Share | n/a |
| Working Capital | 87.07M |
Cash Flow
In the last 12 months, operating cash flow was 49.64 million and capital expenditures -567,439, giving a free cash flow of 49.08 million.
| Operating Cash Flow | 49.64M |
| Capital Expenditures | -567,439 |
| Depreciation & Amortization | 231,732 |
| Net Borrowing | 6.01M |
| Free Cash Flow | 49.08M |
| FCF Per Share | 4.91 |
Margins
Gross margin is 72.49%, with operating and profit margins of 63.05% and 42.38%.
| Gross Margin | 72.49% |
| Operating Margin | 63.05% |
| Pretax Margin | 63.17% |
| Profit Margin | 42.38% |
| EBITDA Margin | 63.25% |
| EBIT Margin | 63.05% |
| FCF Margin | 41.55% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 5.22%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 5.22% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 47.94% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.22% |
| Earnings Yield | 6.63% |
| FCF Yield | 6.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for innoscripta SE is 215.96, which is 186.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 215.96 |
| Price Target Difference | 186.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 32.17% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
innoscripta SE has an Altman Z-Score of 15.59 and a Piotroski F-Score of 4.
| Altman Z-Score | 15.59 |
| Piotroski F-Score | 4 |